Sonic Healthcare FY2026 Results: Strong Performance Achieved
Key points
- Revenue growth of 13% with 5% organic growth
- Underlying EBITDA up 11% and earnings per share up 14%
- Acquisition integration progressing well with synergy realization
- Digital and AI transformation initiatives commenced
- Progressive dividend increased to $1.08 per share
Full summary
Sonic Healthcare Limited (ASX: SHL) reported a robust financial and operational performance for the year ended 30 June 2026, achieving underlying EBITDA earnings guidance through strong revenue growth, operating leverage, and synergy realization. The company saw a 13% increase in revenue, 11% growth in underlying EBITDA, and a 14% rise in underlying earnings per share. Integration of the LADR Laboratory Group acquisition is progressing well, and synergies from recent acquisitions in Switzerland are being captured. The company also initiated digital and AI transformation initiatives and maintained a progressive dividend policy, increasing total dividends to $1.08 per share.
Summary generated by a large language model. Please interpret with care.